A "no-hybrids" screen for functional antagonizers of human p53 transactivator function: dominant negativity in fission yeast
- PMID: 11593407
- DOI: 10.1038/sj.onc.1204702
A "no-hybrids" screen for functional antagonizers of human p53 transactivator function: dominant negativity in fission yeast
Abstract
We have developed a functional "no-hybrids" screen in the fission yeast Schizosaccharomyces pombe based on the transcription transactivator activity of human p53. The screen can be used to identify antagonizers and modulators of p53 activity. Expression of functional full-length human p53 is conditionally lethal to the screen reporter strains. Co-expression of specific inhibitory proteins promotes cell survival and growth. We have validated the "no-hybrids" system by (a) successful modeling of human wild-type p53 interaction with SV40 large T antigen, Mdm2 and a panel of tumor-derived human p53 mutants, (b) demonstrating the screening system's efficiency through identification of a dominant negative fragment of p53 itself in a library screen context and (c) using Drosophila p53 to demonstrate that the system can detect evolutionarily distant p53 homologues based on their transactivator activity. The "no-hybrids" screen will be of utility in searches for p53 function-modulators of both cellular and viral origin.
Similar articles
-
A human tumour-derived mutant p53 protein induces a p34cdc2 reversible growth arrest in fission yeast.Oncogene. 1991 Sep;6(9):1539-47. Oncogene. 1991. PMID: 1923520
-
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.Oncogene. 2004 Mar 25;23(13):2330-8. doi: 10.1038/sj.onc.1207396. Oncogene. 2004. PMID: 14743206
-
p53: an overview of over two decades of study.Malays J Pathol. 2001 Jun;23(1):9-16. Malays J Pathol. 2001. PMID: 16329542 Review.
-
Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.Mol Cell Biol. 2001 Nov;21(22):7629-40. doi: 10.1128/MCB.21.22.7629-7640.2001. Mol Cell Biol. 2001. PMID: 11604499 Free PMC article.
-
Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers.Carcinogenesis. 2007 Feb;28(2):289-98. doi: 10.1093/carcin/bgl132. Epub 2006 Jul 21. Carcinogenesis. 2007. PMID: 16861262
Cited by
-
Reconstitution of Mdm2-dependent post-translational modifications of p53 in yeast.PLoS One. 2008 Jan 30;3(1):e1507. doi: 10.1371/journal.pone.0001507. PLoS One. 2008. PMID: 18231594 Free PMC article.
-
Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial.J Mol Diagn. 2016 Jan;18(1):51-67. doi: 10.1016/j.jmoldx.2015.07.006. Epub 2015 Nov 18. J Mol Diagn. 2016. PMID: 26602013 Free PMC article. Clinical Trial.
-
Techniques to study autophagy in plants.Int J Plant Genomics. 2009;2009:451357. doi: 10.1155/2009/451357. Epub 2009 Aug 27. Int J Plant Genomics. 2009. PMID: 19730746 Free PMC article.
-
TP53: the unluckiest of genes?Cell Death Differ. 2025 Feb;32(2):219-224. doi: 10.1038/s41418-024-01391-6. Epub 2024 Oct 23. Cell Death Differ. 2025. PMID: 39443700 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous